Kailin Xu

7.4k total citations
369 papers, 4.2k citations indexed

About

Kailin Xu is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Kailin Xu has authored 369 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 171 papers in Hematology, 132 papers in Molecular Biology and 96 papers in Oncology. Recurrent topics in Kailin Xu's work include Hematopoietic Stem Cell Transplantation (70 papers), Immune Cell Function and Interaction (55 papers) and CAR-T cell therapy research (53 papers). Kailin Xu is often cited by papers focused on Hematopoietic Stem Cell Transplantation (70 papers), Immune Cell Function and Interaction (55 papers) and CAR-T cell therapy research (53 papers). Kailin Xu collaborates with scholars based in China, United States and Japan. Kailin Xu's co-authors include Lingyu Zeng, Jianlin Qiao, Jiang Cao, Bin Pan, Hai Cheng, Thomas Elliott, Wei Sang, Junnian Zheng, Zhiling Yan and Zhenyu Li and has published in prestigious journals such as Journal of the American Chemical Society, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Kailin Xu

336 papers receiving 4.1k citations

Peers

Countries citing papers authored by Kailin Xu

Since Specialization

Citations

This map shows the geographic impact of Kailin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kailin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kailin Xu more than expected).

Fields of papers citing papers by Kailin Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kailin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kailin Xu. The network helps show where Kailin Xu may publish in the future.

Co-authorship network of co-authors of Kailin Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Kailin Xu. A scholar is included among the top collaborators of Kailin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kailin Xu. Kailin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	p-chlorophenylalanine treatment accelerates tomato fruit ripening through hormone synthesis and glycolytic pathway during storage 2025 ·Postharvest Biology and Technology ·Kailin Xu, (unknown), Hang Zhang, (unknown), Lei Wei, (unknown), Chen Huan, Yan Liu, Xiaolin Zheng, (unknown)	1
2	Nutritional status indices on the prognosis of patients with relapsed and refractory multiple myeloma treated with CAR-T cell immunotherapy 2025 ·Frontiers in Nutrition ·Peng Xu, Yang Liu, Yawen Wang, (unknown), Huanxin Zhang, Hai Cheng, Kunming Qi, Kailin Xu, Zhenyu Li	0
3	Mechanisms underlying resistance to CAR-T cell therapy and strategies for enhancement 2025 ·PubMed ·(unknown), (unknown), (unknown), Yanhua Cao, Rui Zhang, Ruonan Shao, Bofeng Liu, Liting Chen, Kailin Xu, Wei Chen, Jin‐Yuan Ho, Xiaofeng Shi	3
4	Multi-centers experience using therapeutic plasma exchange for corticosteroid/tocilizumab-refractory cytokine release syndrome following CAR-T therapy 2024 ·International Immunopharmacology ·(unknown), (unknown), (unknown), Yang Liu, Meng Zhang, Xia Xiao, Hairong Lyu, Juanxia Meng, Haibo Zhu, Kailin Xu, Weidong Han, Mingfeng Zhao	6
5	Photoredox-promoted from full spectrum photo-driven co-production of dihydroxyacetone and hydrogen peroxide over OV-Bi2O2S/ZnIn2S4 with Bi-S-In bridges 2024 ·Chemical Engineering Journal ·Kailin Xu, Jin Qian, Bianhe Lu, Yuxuan He, Yin Liu, Sijing Tang, (unknown)	1
6	Endothelial Robo4 suppresses endothelial-to-mesenchymal transition induced by irradiation and improves hematopoietic reconstitution 2024 ·Cell Death and Disease ·(unknown), (unknown), Qi Zhou, (unknown), Xiaowen Hao, Yue Li, (unknown), Yujin Huang, Kailin Xu, Jianlin Qiao, (unknown), Lingyu Zeng	4
7	Incidentally cured psoriasis in a patient with refractory/relapsed diffuse large B-cell lymphoma receiving CD19 CAR-T cell therapy: a case report 2024 ·Frontiers in Immunology ·(unknown), Weiming An, (unknown), (unknown), Bin Zhang, Kailin Xu, Shuli Guo, (unknown), Bo Li, Lei Huang, (unknown), Wenyi Guo, (unknown)	6
8	Efficacy and Safety of Inaticabtagene Autoleucel in Children with Relapsed/Refractory (R/R) B-cell Acute Lymphoblastic Leukemia in China 2024 ·Blood ·Shiyuan Wang, Xiaoming Liu, Yongjun Fang, Kailin Xu, Hongsheng Zhou, (unknown), (unknown), (unknown), (unknown), (unknown), Qiliang Peng, (unknown), (unknown)	1
9	Impact of tocilizumab on anti‐CD19 chimeric antigen receptor T‐cell therapy in B‐cell acute lymphoblastic leukemia 2024 ·Cancer ·Xiangmin Wang, (unknown), Qing Zhang, Hongyuan Zhou, (unknown), Yi Zhou, Tianci Li, Dian Zhou, Ziyuan Shen, (unknown), Ping Li, Aibin Liang, Keshu Zhou, Lu Han, Yongxian Hu, Yun Yang, Jiang Cao, Zhenyu Li, Kailin Xu, (unknown)	3
10	The Impact of Pre-Transplant Mental Toughness on Short-Term Outcomes in Lung Allograft Recipients 2024 ·The Journal of Heart and Lung Transplantation ·(unknown), (unknown), Kailin Xu, Jing Liu, Loren Lipworth, Ciara M. Shaver, Anil J. Trindade	0
11	Efficient photocatalytic H2O2 production and green oxidation of glycerol over a SrCoO3-incorporated catalyst 2024 ·Applied Catalysis B: Environmental ·Yuxuan He, Yongming Wang, Jin Qian, Kailin Xu, Bianhe Lu, Sijing Tang, Yin Liu, (unknown)	15
12	Expression of VISTA regulated via IFN-γ governs endogenous T-cell function and exhibits correlation with the efficacy of CD19 CAR-T cell treated B-malignant mice 2024 ·Journal for ImmunoTherapy of Cancer ·(unknown), (unknown), (unknown), (unknown), Kailin Xu, (unknown)	2
13	Platelet-Specific Deletion of TGF-β1 Impairs Septic Thrombosis in Mice—Brief Report 2024 ·Arteriosclerosis Thrombosis and Vascular Biology ·Yingying Li, Huimin Jiang, Xinyi Li, (unknown), (unknown), Jie Zhang, Yueyue Sun, X. Chu, (unknown), Mengdi Xu, Zhenyu Li, Lingyu Zeng, Kailin Xu, Jianlin Qiao	3
14	A combination of pre-infusion serum ferritin, CRP and IL-6 predicts outcome in relapsed/refractory multiple myeloma patients treated with CAR-T cells 2023 ·Frontiers in Immunology ·Yang Liu, (unknown), Nian Li, Ying Wang, Congyue Wang, Jin Ma, (unknown), Qingyun Wu, Jianlin Qiao, Wei Chen, Jiang Cao, Zhiling Yan, Ming Shi, Hai Cheng, Feng Zhu, Wei Sang, Depeng Li, Chong Chen, Kailin Xu, Zhenyu Li	17
15	Intravital lipid droplet labeling and imaging reveals the phenotypes and functions of individual macrophages in vivo 2022 ·Journal of Lipid Research ·Yue Li, (unknown), (unknown), Yuan He, (unknown), (unknown), Wen Ju, Jianlin Qiao, Kailin Xu, Tzu‐Ming Liu, Lingyu Zeng	8
16	Predictive role of endothelial cell activation in cytokine release syndrome after chimeric antigen receptor T cell therapy for acute lymphoblastic leukaemia 2021 ·Journal of Cellular and Molecular Medicine ·Fei Hong, Ming Shi, Jiang Cao, Ying Wang, Yanqing Gong, (unknown), Zhenyu Li, Junnian Zheng, Lingyu Zeng, Aili He, Kailin Xu	23
17	A chimeric antigen receptor with antigen-independent OX40 signaling mediates potent antitumor activity 2021 ·Science Translational Medicine ·Huihui Zhang, Fanlin Li, Jiang Cao, (unknown), Hai Cheng, Kunming Qi, Gang Wang, Kailin Xu, Junnian Zheng, Yang‐Xin Fu, Xuanming Yang	77
18	Activation of JAK/STAT Signaling in Megakaryocytes Sustains Myeloproliferation In Vivo 2019 ·Clinical Cancer Research ·Brittany A. Woods, Wei Chen, Sophia Chiu, Christian Marinaccio, Chunling Fu, (unknown), Marinka Bulic, Qiong Yang, (unknown), Shengxian Jia, Praveen Suraneni, Kailin Xu, Ross L. Levine, John D. Crispino, Qiang Wen	46
19	High expression of miR-363 predicts poor prognosis and guides treatment selection in acute myeloid leukemia 2019 ·Journal of Translational Medicine ·Huihui Zhang, (unknown), Rong Wang, Tingting Shao, (unknown), (unknown), Qingyun Wu, Shengyun Zhu, Jiang Cao, Huan-Xin Zhang, Zhenyu Li, Xuejiao Liu, Mingshan Niu, Kailin Xu	11
20	[Risk Factors and Prognosis of Hepatic cGVHD after Allogeneic Hematopoietic Stem Cell Transplantation]. 2018 ·PubMed ·Di Yu, (unknown), (unknown), Bin Zhang, Huan-Xin Zhang, (unknown), Kunming Qi, Jiang Cao, (unknown), Zhiling Yan, Kailin Xu	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact